Mepixanox, with the CAS number 17854-59-0, is a chemical compound that belongs to the class of piperidine derivatives. It is primarily recognized for its pharmacological properties, particularly as an antidepressant and anxiolytic agent. Mepixanox exhibits a unique mechanism of action, influencing neurotransmitter systems in the brain, which contributes to its therapeutic effects. The compound is characterized by its moderate lipophilicity, allowing it to cross biological membranes effectively. In terms of solubility, Mepixanox is typically soluble in organic solvents, which is common for many piperidine derivatives. Its chemical structure includes a piperidine ring, which is a six-membered ring containing one nitrogen atom, contributing to its biological activity. Mepixanox has been studied for its potential benefits in treating mood disorders, although its clinical use may vary by region and regulatory approval. As with any pharmaceutical compound, understanding its pharmacokinetics, potential side effects, and interactions with other medications is crucial for safe and effective use.

Mepixanox is a respiratory stimulant useful in the treatment of chronic
pneumopathy and other cardiorespiratory insufficiencies, including those induced by
general anesthesia.

Mepixanox

17854-59-0: Mepixanox, with the CAS number 17854-59-0, is a chemical compound that belongs to the class of piperidine derivatives. It is primarily recognized for its pharmacological properties, particularly as an antidepressant and anxiolytic agent. Mepixanox exhibits a unique mechanism of action, influencing neurotransmitter systems in the brain, which contributes to its therapeutic effects. The compound is characterized by its moderate lipophilicity, allowing it to cross biological membranes effectively. In terms of solubility, Mepixanox is typically soluble in organic solvents, which is common for many piperidine derivatives. Its chemical structure includes a piperidine ring, which is a six-membered ring containing one nitrogen atom, contributing to its biological activity. Mepixanox has been studied for its potential benefits in treating mood disorders, although its clinical use may vary by region and regulatory approval. As with any pharmaceutical compound, understanding its pharmacokinetics, potential side effects, and interactions with other medications is crucial for safe and effective use.

Mepixanox is an analeptic drug. It is used for treating respiratory and cardiorespiratory insufficiency.

CAS 17854-59-0

Mepixanox

Mepixanox

Ref: TM-T16041